about
Evidence for Status Epilepticus and Pro-Inflammatory Changes after Intranasal Kainic Acid Administration in MiceDrug delivery systems, CNS protection, and the blood brain barrierPositively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization.Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study.Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study.Using Gelatin Nanoparticle Mediated Intranasal Delivery of Neuropeptide Substance P to Enhance Neuro-Recovery in Hemiparkinsonian Rats.Nanoparticulate drug carriers for delivery of HIV/AIDS therapy to viral reservoir sites.Vessel microport technique for applications in cerebrovascular research.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Intranasal fentanyl for pain control: current status with a focus on patient considerations.Drug delivery approaches for the treatment of glioblastoma multiforme.Nanoneurotherapeutics approach intended for direct nose to brain delivery.Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.A sphingolipid mechanism for behavioral extinction.Comparison of dexmedetomidine and chloral hydrate sedation for transthoracic echocardiography in infants and toddlers: a randomized clinical trial.Preliminary brain-targeting studies on intranasal mucoadhesive microemulsions of sumatriptan.Structural variation governs substrate specificity for organic anion transporter (OAT) homologs. Potential remote sensing by OAT family members.Formulation and evaluation of thermosensitive biogels for nose to brain delivery of doxepin.Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.Organic cation transporters in human nasal primary culture: expression and functional activity.Effect of 12-oxochenodeoxycholate on the pharmacokinetics and pharmacodynamics of morphine 6-glucuronide in Wistar rats.Microemulsion based intranasal delivery system for treatment of insomnia.Brain delivery of olanzapine by intranasal administration of transfersomal vesicles.Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies.Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain-targeting.Nose-to-brain delivery of tacrine.Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay.Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats.Brain targeted delivery of mucoadhesive thermosensitive nasal gel of selegiline hydrochloride for treatment of Parkinson's disease.Development of Nasal Lipid Nanocarriers Containing Curcumin for Brain Targeting.Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting.Intranasal delivery of deferoxamine reduces spatial memory loss in APP/PS1 mice.Intranasal delivery of growth differentiation factor 5 to the central nervous system.First Steps to Develop and Validate a CFPD Model in Order to Support the Design of Nose-to-Brain Delivered Biopharmaceuticals.Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone.From nose to brain: understanding transport capacity and transport rate of drugsNanoparticles combined with growth factors: recent progress and applicationsApplication of Microdialysis for Pharmacokinetics of Traditional Chinese Medicine Studies
P2860
Q28550698-461E774B-D727-43D1-B70A-19FD6DA0A88DQ30432845-C145A58C-0FE5-497B-9E56-AEC259E23A53Q33529835-D7D2FA26-719D-49BA-9D5B-1EB2D257773FQ33563553-EB4B5DFD-64AA-4343-935E-910ACDA8A18AQ34488285-A469DAB3-2844-48FF-9F32-F1BCA1CCD1ABQ35410165-4107F91D-832C-400D-93E7-B6F0EE07265CQ35928366-6FC19C29-B946-46E1-A485-9FFEE645C5D6Q36583732-C57BD1A9-201A-4942-ABB4-15CB8D368E43Q37270325-7CBA18E2-92DC-45B4-B9E6-EA6FF800CA1BQ37416147-57A3ABEB-CA38-4B77-A984-73943E93F541Q37875708-1CF3E5A7-CE22-48AF-93A9-A8ADFEDB3C42Q38517047-5E764A43-48C1-449E-A2C0-907C87F6EA66Q38522125-93B9230B-4993-45B6-BE0D-0A58F9B372FBQ39261027-7FFC9F3F-EB47-4577-869B-D5F7795F4AA2Q40084446-D3B38F95-55D6-4E74-8522-E2CDE725E282Q41089372-2DF38C19-E251-4DC0-992D-5DACE9C53F65Q41831096-67BA8AB8-7C93-462F-9992-6C234FAA6C30Q41905911-2D343CA0-959B-466A-A6B9-69D1AFA557EAQ42724747-72BEF08B-3209-443D-BC4A-E3D23B2E0406Q43083731-8AF6F339-4434-413B-9B07-2914EF2D3A18Q44679946-9B52CA27-EDDC-4405-939C-717CDE830D66Q44960883-73989896-8F4F-4BF6-906F-CF4A4D7D25FCQ45974688-CDAFBD21-93B3-4D37-A0EE-E857E128F3CAQ46358000-971F0653-9C93-4C2E-A6C5-9BF84F21A7C0Q46526710-B5AB6DA2-FE94-4103-93CC-05C95F872D36Q46731832-DAE951B0-46A7-4715-A51C-8E0DB263E916Q46990286-943C4003-8C52-4ED2-8012-F9E1C06B31BDQ47777382-0393B1E7-CE83-454D-8BF8-E319F66D71AAQ47921788-F4C99064-A47A-47F8-9003-D23F90261F7CQ48167102-6D6B7D2E-164C-41D4-B82E-744F73FBD0F7Q48185484-FB5079B4-C342-43E2-8975-E91DE92478F9Q48417067-12BB8B64-FC3F-4488-A254-B4BCA6BCD808Q48489668-E3C21E81-670F-4399-9D5E-E20FC3713518Q48649770-A914327D-6290-4AB2-B075-F20793A70C08Q48898756-4392E6B7-100D-4C06-8F5C-AD795487FECFQ51769316-3C9F1E6A-DC00-4418-9136-6C7F46BE7D60Q56893840-FCD90F31-01CB-4930-830B-035C0067DEF7Q57377197-4DE218B9-8130-4191-9365-CBD886EB14D4Q58171772-D6185F1B-9756-437D-9FF0-873DCA164080
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Intranasal drug delivery for brain targeting.
@ast
Intranasal drug delivery for brain targeting.
@en
type
label
Intranasal drug delivery for brain targeting.
@ast
Intranasal drug delivery for brain targeting.
@en
prefLabel
Intranasal drug delivery for brain targeting.
@ast
Intranasal drug delivery for brain targeting.
@en
P356
P1476
Intranasal drug delivery for brain targeting
@en
P2093
Sudhanva Marathe
Tushar K Vyas
P304
P356
10.2174/1567201053586047
P577
2005-04-01T00:00:00Z